Diabetes Injection Pens Market Continues To Grow Owing To the Increasing Rate of Type 1 Diabetes across the World and Type 2 Diabetes in the Pediatric Population Mainly In Developed Nations

 


Diabetes injection pens are now more commonly used to administer oral diabetes medications to people who have difficulty swallowing. These pens allow the diabetics to inject themselves with a dose of their chosen oral diabetes medication. Insulin pumps and vial style pumps are often used for administering insulin shots and there are also single-dose vials that can be stored in a personal bag or small box and taken at a convenient time.

There are many different types of diabetes injection pens available from medical supply companies offering an array of options to the consumer. These are made of rubber latex or similar flexible material that is durable and resistant to infection. The needles are usually made of sterile stainless steel but rubber inserts are available for use with some units. Depending on what brand and type of diabetes medicine are being ordered, the pen will be embossed with the letter of the patient's first name, the word "diabetic" or another symbol indicating this fact and their personal information.

Market Dynamics                                  

The main factor driving the growth of the diabetes injection pens market is the rapid increase of diabetes across the globe. For instance, according to a 2020 report by CDC approximately 34.2 million people were suffering from diabetes. The new cases of diabetes are high among non-Hispanic blacks than non-Hispanic whites and non-Hispanic Asians. Other factors such as injuries caused due to needle sticks and bacterial infections caused by regular usages of syringes are estimated to propel the market growth of the insulin injection pens market.

However, the abundance of insulin patches, and other safer substitute for insulin injection pens are the main restraining factors hindering the growth of the market.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these North America is estimated to hold a significant share of the diabetes injection pens market owing to the increasing rate of type-1 diabetes and the development of new, safer to use pens by key players in the region. For instance, according to the Americans with Disabilities Act (ADA), in 2018, approximately 1.25 million people were suffering from type 1 diabetes. ADA estimates that around 40,000 people get diagnosed with Type 1 diabetes every year. The diabetes injection pens market in the Asia Pacific is estimated to witness significant growth owing to the rising concerns among the patients and the development and expansion of healthcare sectors.

Competitive Analysis

Key players operating in the global diabetes injection pens market include Jiangsu Delfu Co., Dickinson and Company, Becton, Eli Lilly and Company, Biocon Ltd, AstraZeneca Plc, and Novo Nordisk A/S.

In June 2019, Victoza was the first non-insulin drug that was approved for children aged 10 years and above for treating type 2 diabetes.

 


Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers aroun...
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 ...
Read more

Increasing Prevalence of Muscular Dystrophy to Augment the Muscular Dystrophy Treatment Market Growth

Image
  Muscular dystrophy is a common disease that causes muscles to become weaker and unable to continue to develop properly. Because it often affects young children as well as adults, it can be difficult to detect. However, once symptoms are noticed, steps must be taken to prevent the disease. There are many treatment options available for muscular dystrophy. The severity of the disease will determine what type of treatment is best for your situation. Muscular dystrophy treatment involves breathing aids, therapy, surgery, or medication, which may help maintain function, but life span is often shortened. Market Dynamics: Increasing prevalence or incidence of muscular dystrophy, especially in the North America, is expected to propel the growth of the muscular dystrophy treatment market . For instance, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy (DMD), according to the National Organization for Rare Disorders. Moreover, in 2019, around 349 ne...
Read more